Univariable | Multivariable | |||
---|---|---|---|---|
TE’s over 24-months | TE’s over 24-months | |||
N = 168 | N = 168 | |||
Coef (95% CI) | P-value | Coef (95% CI) | P-value | |
Main Predictor | ||||
Hamada Grade | ||||
Stage 2 | REF | REF | ||
Stage 3 | 0.06 (−0.03, 0.14) | 0.194 | 0.05 (−0.03, 0.14) | 0.229 |
Stage 4a; Stage 4b; Stage 5 | 0.07 (− 0.01, 0.14) | 0.07 | 0.08 (0.00, 0.15) | 0.042 |
Confounders | ||||
Age | ||||
< 70 | REF | REF | ||
70 to 80 | 0.01 (−0.07, 0.08) | 0.894 | 0.02 (−0.05, 0.10) | 0.546 |
80+ | 0.07 (−0.03, 0.17) | 0.177 | 0.09 (−0.01, 0.20) | 0.087 |
Gender | ||||
Female | REF | REF | ||
Male | −0.02 (−0.08, 0.05) | 0.604 | −0.02 (− 0.09, 0.04) | 0.518 |
Dominant side | ||||
Dominant | REF | REF | ||
Non-dominant | −0.07 (−0.17, 0.04) | 0.213 | −0.10 (− 0.21, 0.01) | 0.07 |
ASA grade | ||||
1 | REF | REF | ||
2 | −0.03 (−0.17, 0.11) | 0.673 | −0.02 (− 0.16, 0.12) | 0.79 |
3 | −0.07 (− 0.19, 0.06) | 0.28 | − 0.09 (− 0.21, 0.03) | 0.157 |
4 and 5 | − 0.11 (− 0.24, 0.01) | 0.065 | −0.16 (− 0.28, − 0.03) | 0.013 |